Two projects supported by SATT Nord receive awards from Matwin's International Board

Under the leadership of Professor Josy REIFFERS, President of MATWIN, the members […]

Under the leadership of Professor Josy REIFFERS, President of MATWIN, theBoard members reviewed the best projects identified through the MATWIN selection process during the 6th meeting of the MATWIN International Boardon May 12 and 13, 2015, in Bordeaux.

Over two days, eight project leaders presented the results of their research to an audience of renowned figures, academic opinion leaders, and representatives from the 11 international pharmaceutical companies partnering with the program. Discussions with the project leaders and the recommendations once again added significant value to the eight projects presented.Six of the eight projects received a positive recommendation, and three of them received an honorary award from the MATWIN Board.

Best project addressing an unmet medical need
⇒ Galinib: New anti-tumor immunotherapy based on neutralizing the suppressive activity of regulatory T cells using monoclonal antibodies targeting Galectin-9. Matwin's International Board has also awarded exceptional funding to this project (€30k) to facilitate the humanization of the Gal-Nab1 antibody.

Dr. Nadira DELHEM, Tumorigenesis Mechanisms and Targeted Therapies Laboratory – Lille Institute of Biology
 

Best disruptive innovation  
⇒ SpiderMass : real-time guided surgery using mass spectrometry
Prof. Isabelle FOURNIER and Prof. Michel SALZET, Proteomics, Inflammatory Response, and Mass Spectrometry Laboratory, University of Lille 1
These funding envelopes will bolster support for the maturation of projects already in place within their respective commercialization structures (SATT or Inserm Transfert) and optimize their potential for industrial appeal with a view to collaboration or transfer.

According to Lucia Robert (Director of Matwin), "The SATTs are already fully integrated into the Matwin process. They are informed of all the projects we are pursuing and participate in project coaching," convinced that the national level is more relevant than the regional level for promoting highly specialized research such as oncology research.

All information at:http://www.matwin.org/actualites/6e_edition_du_board_international_de_matwin-a44.html